These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32861769)

  • 1. Application of 3D printing technology for generating hollow-type suppository shells.
    Tagami T; Ito E; Hayashi N; Sakai N; Ozeki T
    Int J Pharm; 2020 Nov; 589():119825. PubMed ID: 32861769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D printing of unique water-soluble polymer-based suppository shell for controlled drug release.
    Tagami T; Hayashi N; Sakai N; Ozeki T
    Int J Pharm; 2019 Sep; 568():118494. PubMed ID: 31276763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of timed-release indomethacin core-shell tablets for chronotherapeutic drug delivery using dual nozzle fused deposition modeling (FDM) 3D printing.
    Chung S; Zhang P; Repka MA
    Eur J Pharm Biopharm; 2023 Jul; 188():254-264. PubMed ID: 37201727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and
    Kaidierya A; Zhang RG; Qian HN; Zou ZY; Danniya Y; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1202-1207. PubMed ID: 36533356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and
    Li ZS; Qian HN; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 54(3):572-577. PubMed ID: 35701138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and
    Chen D; Xu XY; Wang MR; Li R; Zang GA; Zhang Y; Qian HN; Yan GR; Fan TY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):348-354. PubMed ID: 33879910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Incorporation into Polymer Filament Using Simple Soaking Method for Tablet Preparation Using Fused Deposition Modeling.
    Tagami T; Kuwata E; Sakai N; Ozeki T
    Biol Pharm Bull; 2019; 42(10):1753-1760. PubMed ID: 31582663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3D Printing Factors Important for the Fabrication of Polyvinylalcohol Filament-Based Tablets.
    Tagami T; Fukushige K; Ogawa E; Hayashi N; Ozeki T
    Biol Pharm Bull; 2017; 40(3):357-364. PubMed ID: 28250279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
    Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
    Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fused Deposition Modeling (FDM) 3D Printed Tablets for Intragastric Floating Delivery of Domperidone.
    Chai X; Chai H; Wang X; Yang J; Li J; Zhao Y; Cai W; Tao T; Xiang X
    Sci Rep; 2017 Jun; 7(1):2829. PubMed ID: 28588251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a simple paste for 3D printing of drug formulations containing a mesoporous material loaded with a poorly water-soluble drug.
    Katsiotis CS; Tikhomirov E; Leliopoulos C; Strømme M; Welch K
    Eur J Pharm Biopharm; 2024 May; 198():114270. PubMed ID: 38537908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesalazine hollow suppositories based on 3D printing for treatment of ulcerative colitis.
    Wei M; Liu D; Sun Y; Xie H; Du L; Jin Y
    Int J Pharm; 2023 Jul; 642():123196. PubMed ID: 37399930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabrication of Zero-Order Sustained-Release Floating Tablets via Fused Depositing Modeling 3D Printer.
    Kimura SI; Ishikawa T; Iwao Y; Itai S; Kondo H
    Chem Pharm Bull (Tokyo); 2019; 67(9):992-999. PubMed ID: 31474738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3D-printed prednisolone phosphate suppositories with tunable dose and rapid release for the treatment of inflammatory bowel disease.
    Kocabas LI; Ayyoubi S; Tajqurishi M; Quodbach J; Vermonden T; Kok RJ
    Int J Pharm; 2024 Jan; 649():123639. PubMed ID: 38042381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lyophilized ophthalmologic patches as novel corneal drug formulations using a semi-solid extrusion 3D printer.
    Tagami T; Goto E; Kida R; Hirose K; Noda T; Ozeki T
    Int J Pharm; 2022 Apr; 617():121448. PubMed ID: 35066116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QbD guided development of immediate release FDM-3D printed tablets with customizable API doses.
    Crișan AG; Iurian S; Porfire A; Rus LM; Bogdan C; Casian T; Lucacel RC; Turza A; Porav S; Tomuță I
    Int J Pharm; 2022 Feb; 613():121411. PubMed ID: 34954001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
    Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
    Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
    Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
    Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance and paroxetine stability in tablets manufactured by fused deposition modelling-based 3D printing.
    Figueiredo S; Fernandes AI; Carvalho FG; Pinto JF
    J Pharm Pharmacol; 2022 Jan; 74(1):67-76. PubMed ID: 34591102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melt extrusion deposition (MED™) 3D printing technology - A paradigm shift in design and development of modified release drug products.
    Zheng Y; Deng F; Wang B; Wu Y; Luo Q; Zuo X; Liu X; Cao L; Li M; Lu H; Cheng S; Li X
    Int J Pharm; 2021 Jun; 602():120639. PubMed ID: 33901601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.